Search

Author/Creator Park, Yeon Hee

1. 288 A phase 1 study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors. (9th November 2020)

Authors:
Keam, Bhumsuk; Kim, Tae Min; Oh, Do-Youn; Ock, Chan-Young; Kang, Won Ki; Park, Yeon Hee; Lee, Jeeyun; Lee, Ji Hye; Song, Yun Jeong; Park, Young Suk
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A315
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase II trial of the pan‐HER inhibitor poziotinib, in patients with HER2‐positive metastatic breast cancer who had received at least two prior HER2‐directed regimens: results of the NOV120101‐203 trial. Issue 12 (7th November 2018)

Authors:
Park, Yeon Hee; Lee, Kyung‐Hun; Sohn, Joo Hyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee‐Hyun; Lee, Ki Hyeong; Ahn, Jin Seok; Kim, Tae‐Yong; Kim, Gun Min; Park, In Hae; Kim, Sung‐Bae; Kim, Se Hyun; Han, Hye Sook; Im, Young‐Hyuck; Ahn, Jin‐Hee; Kim, Jung‐Yong; Kang, Jahoon; Im, Seock‐Ah
Journal:
International journal of cancer
Issue:
Volume 143:Issue 12(2018)
Page Start:
3240
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A seven‐gene signature can predict distant recurrence in patients with triple‐negative breast cancers who receive adjuvant chemotherapy following surgery. Issue 8 (24th December 2014)

Authors:
Park, Yeon Hee; Jung, Hae Hyun; Do, In‐Gu; Cho, Eun Yoon; Sohn, Insuk; Jung, Sin‐Ho; Kil, Won Ho; Kim, Seok Won; Lee, Jeong Eon; Nam, Seok Jin; Ahn, Jin Seok; Im, Young‐Hyuck
Journal:
International journal of cancer
Issue:
Volume 136:Issue 8(2015:Apr. 15)
Page Start:
1976
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study. Issue 4 (April 2021)

Authors:
Rugo, Hope S; Lerebours, Florence; Ciruelos, Eva; Drullinsky, Pamela; Ruiz-Borrego, Manuel; Neven, Patrick; Park, Yeon Hee; Prat, Aleix; Bachelot, Thomas; Juric, Dejan; Turner, Nicholas; Sophos, Nickolas; Zarate, Juan Pablo; Arce, Christina; Shen, Yu-Ming; Turner, Stuart; Kanakamedala, Hemanth; H...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 4(2021)
Page Start:
489
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity. Issue 2 (19th October 2020)

Authors:
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity. Issue 2 (19th October 2020)

Authors:
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity. Issue 2 (19th October 2020)

Authors:
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity. Issue 2 (19th October 2020)

Authors:
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity. Issue 2 (19th October 2020)

Authors:
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗